The Project Leader, Commercial Glycobiology Product is responsible for creating and leading a team responsible for translating successful in vitro results of liposomally-encapsulated glycobiology compound against HCV into commercial products.
2010-2012 in Silver Spring, MD; 2013-Thereafter in Oxford, UK
Successfully obtained regulatory approval of an anti-viral, preferably HBV or HCV. Successfully helped develop a liposomally-encapsulated product.
Qualified candidates please click here to apply!
EOE